Durvalumab increases the risk of radiation pneumonitis in non-small-cell lung cancer patients

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S323-S324
Number of pages2
JournalRadiotherapy and Oncology
Volume170
Publication statusPublished - May-2022

Cite this